In 2023, the global nephelometry kits market is expected to be worth USD 860.4 million. The market is expected to reach USD 1.4 billion by 2033, expanding at a 5.5% CAGR throughout the forecast period. The manufacturing, marketing, and use of nephelometry kits for diagnostic purposes is referred to as the nephelometry kits market. A laboratory procedure called nephelometry is used to assess the levels of particular analytes in a patient’s blood or other body fluids. A variety of biomarkers can be measured precisely and accurately with nephelometry kits, enabling medical personnel to identify and track a wide range of illnesses and ailments.
Nephelometry kit sales have increased significantly in recent years for a variety of reasons. The demand for precise and trustworthy diagnostic instruments, such as nephelometry kits, has increased as chronic diseases like cardiovascular disorders, autoimmune diseases, and renal diseases are becoming more common. Additionally, the ageing population, which is more susceptible to a number of diseases.
Nephelometry is a precise and specific diagnostic test that is needed to discover illness biomarkers and track therapy response due to the shift towards personalized medicine and targeted medicines. By delivering precise and fast measurements of disease-specific biomarkers, nephelometry kits play an important part in enabling personalized treatment.
The development of multiplex nephelometry assays, which can test many biomarkers simultaneously, is becoming increasingly important in terms of market trends. As a result, fewer individual assays are required and more comprehensive diagnostic information can be obtained from a single test. Point-of-care nephelometry testing is also getting increased attention since it allows for quick on-site diagnosis, especially in emergency situations or locations with limited resources.
Key Takeaways from the Nephelometry Kits Market:
- The nephelometry kits industry in the United States is predicted to reach USD 540.3 million by 2033, increasing at a 6.8% CAGR.
- The nephelometry kits industry in the United Kingdom is estimated to reach a market value of USD 55.5 million, expanding at a CAGR of 6.1% by 2033.
- During the forecast period, the nephelometry kits industry in China is expected to reach a market value of USD 194.4 million, securing a 7.6% CAGR.
- The nephelometry kits industry in Japan is predicted to reach USD 54.8 million by 2033, increasing at a 5.6% CAGR.
- South Korea’s nephelometry kits industry is predicted to achieve a market value of USD 20.3 million, rising at a 5.6% CAGR during the forecast period.
- With a CAGR of 6.1% from 2023 to 2033, the reagent kits segment is expected to dominate the nephelometry kits industry.
- With a CAGR of 6.8% from 2023 to 2033, the serum segment is expected to dominate the nephelometry kits industry.
- With a CAGR of 5.7% from 2023 to 2033, the disease diagnosis is expected to dominate the nephelometry kits industry.
- With a CAGR of 5.3% from 2023 to 2033, the hospital is expected to dominate the nephelometry kits industry.
Rising Interest in Market Trends: Our Detailed Report Provides Essential Insights!
How Does the Competition Look in the Nephelometry Kits Market?
The nephelometry kits sector is a very competitive one, with many firms fighting for market share. Several significant participants in this industry Siemens Healthineers, F. Hoffmann-La Roche Ltd., Thermo, Beckman Coulter, Inc. (Danaher), Agilent Technologies, Inc., Elabscience Biotechnology Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Goldsite Diagnostics Inc., Randox Laboratories Ltd., Hipro Biotechnology Co., Ltd., Beijing Strong Biotechnologies, Inc., Getein Biotech, Inc.
The main corporations are investing extensively in research and development efforts to develop inventive and creative products with improved reliability, efficacy, and cost. In order to meet changing consumer expectations, they are also concentrating on extending their product portfolio and bolstering their distribution strategies.
Industry-wide, tactical alliances and partnerships with other businesses are more frequent, enabling parties to capitalize on one another’s advantages and increase their market power.
Leading companies employ mergers and consolidation to expand into new markets and improve their market share. In emerging markets, particularly in China and India, the sector is rapidly growing.
Major corporations are developing regional production facilities and increasing their distribution networks to increase their presence in these areas. In order to gain a competitive edge, they are also focusing on providing customers in these markets with solutions that are affordable.
Key Developments in the Nephelometry Kits Market:
- In April 2020, The SARS-CoV-2 Assay test kit from Siemens Healthineers, which detects the coronavirus (Covid-19) disease-causing SARS-CoV-2 virus, has been made available.
- In October 2022, A shareholder group led by the European equity firm Nordic Capital has entered into a definitive deal for Thermo Fisher Scientific to buy The Binding Site Group, a specialty diagnostics business.
Segmentation Analysis of the Nephelometry Kits Market:
By Product:
- Reagent Kits
- Albumin Test
- Microglobulin Albumin Test
- C-Reactive Protein Test
- Fibrinogen Test
- Fibronectin Test
- Haptoglobin Test
- Kappa Light Chains
- Lambda Light Chains
- Transferrin Test
- Alpha-1-Acid Glycoprotein Test
- Alpha-1-Antitrypsin Test
- Apolipoprotein B Test
- Cystatin Test
- Ferritin Test
- Immunoglobulin Test
- Lipoprotein Test
- Others
- Controls Kits/Reagents
By Sample Type:
- Serum
- Plasma
- Urine
- Cerebrospinal Fluid
- Others
By Application:
- Drug Discovery and Development
- Disease Diagnosis
- Cancer
- Infectious Diseases
- Blood Coagulation
- Renal Function
- Liver Disease
- Autoimmune Disorders
- Others
- Other Application
By End User:
- Hospital
- Diagnostic Laboratories
- Reference Laboratories
- Specialty Clinics/Standalone
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
